We report a novel transthyretin variant, Gly53Ala, in a 44-year-old British woman who presented with severe episodic headaches, often with focal neurological deficit, before developing progressive ataxia, depression, dementia and eventually peripheral neuropathy. Transthyretin amyloidosis was confirmed on biopsy of the heart muscle. Serum amyloid P component scintigraphy did not show visceral amyloid in extra-cardiac sites, but magnetic resonance imaging indicated diffuse leptomeningeal amyloidosis.
- CNS, central nervous system
- CSF, cerebrospinal fluid
- FAP, familial amyloid polyneuropathy
- TTR, transthyretin
Statistics from Altmetric.com
Competing interests: None.
Informed consent was obtained from the patient for publication of her details in this paper.